GrowBLOX Sciences, Inc. (GBLX) Names John Poss as
Post# of 118
Posted On: 08/25/2015 5:08:18 PM
GrowBLOX Sciences, Inc. (GBLX) Names John Poss as New CFO
GrowBLOX Sciences (OTC: GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, today announced John Poss as its new chief financial officer.
“First joining us as a consultant, the performance of John Poss and his impact on our company, made the hiring of him as a full-time key executive an obvious choice. This choice supports our transition from the engineering intensive development stage to the day-to-day operations of producing an excellent product, branding it appropriately, and maximizing our revenue. We feel that John will be instrumental in helping us to achieve that transition smoothly and expeditiously,” stated GrowBLOX Sciences CEO Craig Ellins. “John’s experience, in business and in life, speaks for itself.”
The company describes Poss as having “an aptitude for solving complex problems and improving performance in technology, logistics, business systems, and finance.” Poss previously served as CFO, CEO, COO, and CTO of both public and private companies with sales ranging from $10 million to $450 million as well as over 15 years of consulting experience. He also has extensive M&A experience, both buy and sell side, including private equity. His success has been demonstrated across multiple industries, including telecommunications, transportation/logistics, manufacturing, finance/mortgage, construction, mining, oil, gas, and public accounting/consulting. Additionally, he is a proven innovator with two issued patents. Further, he’s led major projects and negotiated over $1 billion in commercial agreements and dispute resolutions in 15 countries.
“I am very happy to join GrowBLOX. As a cancer survivor, I am a strong believer in the value of medical marijuana in many cases and to treat many diseases. I am excited to be a part of this revolution, which has been developing, slowly, throughout my lifetime,” stated Poss.
For more information visit http://growblox.com.
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
GrowBLOX Sciences (OTC: GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, today announced John Poss as its new chief financial officer.
“First joining us as a consultant, the performance of John Poss and his impact on our company, made the hiring of him as a full-time key executive an obvious choice. This choice supports our transition from the engineering intensive development stage to the day-to-day operations of producing an excellent product, branding it appropriately, and maximizing our revenue. We feel that John will be instrumental in helping us to achieve that transition smoothly and expeditiously,” stated GrowBLOX Sciences CEO Craig Ellins. “John’s experience, in business and in life, speaks for itself.”
The company describes Poss as having “an aptitude for solving complex problems and improving performance in technology, logistics, business systems, and finance.” Poss previously served as CFO, CEO, COO, and CTO of both public and private companies with sales ranging from $10 million to $450 million as well as over 15 years of consulting experience. He also has extensive M&A experience, both buy and sell side, including private equity. His success has been demonstrated across multiple industries, including telecommunications, transportation/logistics, manufacturing, finance/mortgage, construction, mining, oil, gas, and public accounting/consulting. Additionally, he is a proven innovator with two issued patents. Further, he’s led major projects and negotiated over $1 billion in commercial agreements and dispute resolutions in 15 countries.
“I am very happy to join GrowBLOX. As a cancer survivor, I am a strong believer in the value of medical marijuana in many cases and to treat many diseases. I am excited to be a part of this revolution, which has been developing, slowly, throughout my lifetime,” stated Poss.
For more information visit http://growblox.com.
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
(0)
(0)GB Sciences, Inc. (GBLX) Stock Research Links
Scroll down for more posts ▼